This HTML5 document contains 110 embedded RDF statements represented using HTML+Microdata notation.

The embedded RDF content will be recognized by any processor of HTML5 Microdata.

Namespace Prefixes

PrefixIRI
wdthttp://www.wikidata.org/prop/direct/
wdtnhttp://www.wikidata.org/prop/direct-normalized/
schemahttp://schema.org/
skoshttp://www.w3.org/2004/02/skos/core#
rdfshttp://www.w3.org/2000/01/rdf-schema#
n12http://dx.doi.org/10.1007/
wikibasehttp://wikiba.se/ontology#
phttp://www.wikidata.org/prop/
rdfhttp://www.w3.org/1999/02/22-rdf-syntax-ns#
n7http://rdf.ncbi.nlm.nih.gov/pubchem/reference/
xsdhhttp://www.w3.org/2001/XMLSchema#
wdshttp://www.wikidata.org/entity/statement/
n13https://scigraph.springernature.com/pub.10.1007/
wdhttp://www.wikidata.org/entity/

Statements

Subject Item
wd:Q56972032
rdf:type
wikibase:Item
schema:description
article scientifique publié en 2014 article наукова стаття, опублікована в грудні 2014 im Dezember 2014 veröffentlichter wissenschaftlicher Artikel wetenschappelijk artikel
p:P577
wds:Q56972032-916A82C0-8F1A-408B-ADB8-0C98A75EAA1B
wdt:P577
2014-09-20T00:00:00Z
p:P407
wds:Q56972032-C5B5613D-BB90-41A4-B209-E68F56E7419B
wdt:P407
wd:Q1860
p:P2888
wds:Q56972032-416A56A4-A525-45FB-9E95-6A13147B603F
wdt:P2888
n13:s00228-014-1755-1
p:P2860
wds:Q56972032-1D90FD80-C91E-44C0-BFC4-6BEE2D107DE8 wds:Q56972032-11D7963B-42EA-4657-8ED4-C2A2B6F1A8E2 wds:Q56972032-FB1FAE53-88E9-4835-99CA-DED5620270ED wds:Q56972032-FBCA01C4-6BC5-4DE4-9096-F9D42EA7C764 wds:Q56972032-F2D50856-0E80-444F-BCC3-B31907430AD7 wds:Q56972032-F2D9753F-E5BB-4D5A-AC89-44EF49857964 wds:Q56972032-F505119A-80B0-42DB-B294-3780F8B293FA wds:Q56972032-EA39787E-03DB-4974-916F-41BD0070120A wds:Q56972032-C6CF6A40-420F-4388-9CE9-2743961C8CE3 wds:Q56972032-B9DC8C67-24BC-4792-A66A-C0FD82250695 wds:Q56972032-89E1BE9C-5F97-4D1F-B0AB-ED717BCDE7AD wds:Q56972032-9086CA98-E953-4C14-A08C-AA4BA71CACFD wds:Q56972032-61706459-F880-4881-9738-F6599CD37664 wds:Q56972032-6591DCAD-1071-46FD-81EE-F9195083AB61 wds:Q56972032-50055EC6-C2DB-411D-8225-4CC2BB3A6C09 wds:Q56972032-569BA7EB-8DC9-4459-A620-1284091BED3C wds:Q56972032-43F2E47B-D5D2-4806-8CF8-E40DB294FB47 wds:Q56972032-4AB35B8A-644F-4E6D-8E39-D23F7922486C wds:Q56972032-326E9C6A-60A1-487D-BFBB-1F66A69524B3 wds:Q56972032-3373A87C-B0AF-4490-9910-78470D8340E1 wds:Q56972032-280CA0D8-B9AF-4430-A01F-4F01C24EB847 wds:Q56972032-2A3FD196-EFF4-4B12-98AF-68B04A1465EE wds:Q56972032-18D341FC-296D-453E-A5BC-07E378412970
wdt:P2860
wd:Q46478081 wd:Q79817474 wd:Q38009430 wd:Q85245793 wd:Q45966227 wd:Q33223154 wd:Q35162123 wd:Q37369644 wd:Q28294837 wd:Q21090878 wd:Q44249268 wd:Q47857376 wd:Q60197408 wd:Q37839380 wd:Q46960496 wd:Q30436143 wd:Q34608306 wd:Q36075546 wd:Q24616209 wd:Q80420502 wd:Q35089918 wd:Q33982800 wd:Q37109788
p:P2093
wds:Q56972032-172BBC9E-ED3F-4205-9AA5-312A73FE29FB wds:Q56972032-52456201-EB55-4B04-97D3-4ED67B879CEE wds:Q56972032-34775963-3349-4461-9AFE-48B469DF802A wds:Q56972032-CBF1B05D-4BB6-46E0-8182-283FEC2A8FED wds:Q56972032-CA9AB67F-EE9B-4D1E-8308-5A767E256702 wds:Q56972032-CD37D0FE-AF23-43DC-BD63-21D8720F4217 wds:Q56972032-E8A3BCC5-2880-4182-B201-B1AB8E602B9B wds:Q56972032-670BF484-A213-4959-802C-05C19A341785 wds:Q56972032-AEE4556B-03AE-44C9-9FBD-1EE47CC00D06 wds:Q56972032-F4C290A8-1D14-42F6-8C5D-30DC42D094EE
wdt:P2093
N Montanaro M Melis R Amato V Conti L Pazzi A Vaccheri A Covezzoli M Donati C Biagi E Buccellato
rdfs:label
Comparative safety profiles of intravitreal bevacizumab, ranibizumab and pegaptanib: the analysis of the WHO database of adverse drug reactions Comparative safety profiles of intravitreal bevacizumab, ranibizumab and pegaptanib: the analysis of the WHO database of adverse drug reactions
skos:prefLabel
Comparative safety profiles of intravitreal bevacizumab, ranibizumab and pegaptanib: the analysis of the WHO database of adverse drug reactions Comparative safety profiles of intravitreal bevacizumab, ranibizumab and pegaptanib: the analysis of the WHO database of adverse drug reactions
schema:name
Comparative safety profiles of intravitreal bevacizumab, ranibizumab and pegaptanib: the analysis of the WHO database of adverse drug reactions Comparative safety profiles of intravitreal bevacizumab, ranibizumab and pegaptanib: the analysis of the WHO database of adverse drug reactions
p:P50
wds:Q56972032-65C33F66-589E-410D-94C7-169923CA9DB3 wds:Q56972032-CB1A9656-9C9D-4EE8-9C97-7634AA420943
wdt:P50
wd:Q56107792 wd:Q42682142
p:P1476
wds:Q56972032-57F75393-681D-4F2F-9C76-9F973474F498
wdt:P1476
Comparative safety profiles of intravitreal bevacizumab, ranibizumab and pegaptanib: the analysis of the WHO database of adverse drug reactions
p:P304
wds:Q56972032-A72D7DFD-A721-4243-B7DD-C1D3973E15E9
wdt:P304
1505-1512
p:P31
wds:Q56972032-1B78A4A3-AB67-4D95-8C20-2C771C350FB4
wdt:P31
wd:Q13442814
p:P921
wds:Q56972032-64B0FBF3-DE69-4704-995F-A2F719DB3847 wds:Q56972032-3AD5A5A7-3365-4E4B-90A3-2C96D3FF5E08
wdt:P921
wd:Q413299 wd:Q7817
p:P698
wds:Q56972032-EB84C775-74AE-4F69-8342-F3417E9EACCC
wdtn:P698
n7:25234795
wdt:P698
25234795
p:P1433
wds:Q56972032-25E9EA0E-B85E-41C8-9150-E2664BBD5353
wdt:P1433
wd:Q1376707
p:P433
wds:Q56972032-29AADA13-9787-4E52-9AAA-4789E4F5DB4E
p:P478
wds:Q56972032-3BA29DB6-D79C-4850-9327-FE77D55ECB9F
wdt:P433
12
wdt:P478
70
p:P356
wds:Q56972032-FA788E23-5EE5-48A8-959F-3CFDE1D70D98
wdtn:P356
n12:S00228-014-1755-1
wdt:P356
10.1007/S00228-014-1755-1